Array
(
[id] => 6507845
[patent_doc_number] => 20100216237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'OPTIMIZED AND DEFINED METHOD FOR ISOLATION AND PRESERVATION OF PRECURSOR CELLS FROM HUMAN UMBILICAL CORD'
[patent_app_type] => utility
[patent_app_number] => 12/680604
[patent_app_country] => US
[patent_app_date] => 2008-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 11603
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216237.pdf
[firstpage_image] =>[orig_patent_app_number] => 12680604
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/680604 | Optimized and defined method for isolation and preservation of precursor cells from human umbilical cord | Oct 2, 2008 | Issued |
Array
(
[id] => 6134402
[patent_doc_number] => 20110008304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'USE OF CELLS TO FACILITATE TARGETED DELIVERY OF NANOPARTICLE THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 12/668281
[patent_app_country] => US
[patent_app_date] => 2008-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22841
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008304.pdf
[firstpage_image] =>[orig_patent_app_number] => 12668281
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/668281 | USE OF CELLS TO FACILITATE TARGETED DELIVERY OF NANOPARTICLE THERAPIES | Jul 8, 2008 | Abandoned |
Array
(
[id] => 8920737
[patent_doc_number] => 08486669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Enzymatic hydrolysis of a cellulose material treated with an ionic liquid'
[patent_app_type] => utility
[patent_app_number] => 12/523327
[patent_app_country] => US
[patent_app_date] => 2008-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 21472
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12523327
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523327 | Enzymatic hydrolysis of a cellulose material treated with an ionic liquid | Jan 21, 2008 | Issued |
Array
(
[id] => 12406614
[patent_doc_number] => 09969134
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Nanopatterned biopolymer optical device and method of manufacturing the same
[patent_app_type] => utility
[patent_app_number] => 12/513394
[patent_app_country] => US
[patent_app_date] => 2007-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 36
[patent_no_of_words] => 7966
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 180
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12513394
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513394 | Nanopatterned biopolymer optical device and method of manufacturing the same | Nov 4, 2007 | Issued |
Array
(
[id] => 9216146
[patent_doc_number] => 08628946
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity'
[patent_app_type] => utility
[patent_app_number] => 10/559272
[patent_app_country] => US
[patent_app_date] => 2004-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 12
[patent_no_of_words] => 6374
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10559272
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/559272 | Phl p 5a derivatives having reduced allergeneity and retained T-cell reactivity | May 5, 2004 | Issued |